The Latest Cardiac and Vascular News
VANCOUVER and MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire —Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021. Third Quarter Highlights Strong progress against all three value creation strategies. Generated record revenue of approximately $703,000 in the quarter, up […]
SUNNYVALE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended September 30, 2021. “I am incredibly proud of our team for continuing to drive TCAR […]
SILVER SPRING, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2021. “Despite […]
Non-Invasive Technology Requires No Vests, CT or MRI Imaging, or Invasive Mapping SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 fourth quarter ended September 30, 2021 and provided its financial outlook for its fiscal 2022. Summary of Fourth Quarter and Recent […]
Collaboration will empower clinicians with AI-enhanced diagnostics for heart failure and coronary artery disease beyond the walls of the hospital BRISBANE, Calif., OXFORD, England and GUILFORD, Conn., Nov. 9, 2021 /PRNewswire/ — Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced a strategic partnership to accelerate cardiovascular disease detection […]
ScanWatch, which received FDA clearance for atrial fibrillation detection through ECG and measuring SpO2 levels from the wrist, becomes available in the United States ISSY-LES-MOULINEAUX, France, Nov. 9, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, begins U.S. sales of ScanWatch, its award-winning and most advanced health wearable to date. Available from […]
SANTA CLARA, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2021. Recent Highlights Recognized revenue of $65.2 million […]
THE WOODLANDS, Texas, Nov. 09, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that a new analysis of sotagliflozin results from the SOLOIST and SCORED Phase 3 outcomes studies will be presented at the virtual American Heart Association Scientific Sessions 2021. The new analysis will be presented by Deepak […]
All additional testing of devices manufactured on the planned commercial line, as required by the FDA, has been successful to date FUROSCIX® NDA resubmission anticipated for Q1 2022 due to COVID-19 related global supply chain logistics interruptions and travel restrictions Revised NDA resubmission timeline is not expected to have an […]
